Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in India. by Arora, Narendra K et al.
LSHTM Research Online
Arora, Narendra K; Nair, MKC; Gulati, Sheffali; Deshmukh, Vaishali; Mohapatra, Archisman; Mishra,
Devendra; Patel, Vikram; Pandey, Ravindra M; Das, Bhagabati C; Divan, Gauri; +58 more... Murthy,
GVS; Sharma, Thakur D; Sapra, Savita; Aneja, Satinder; Juneja, Monica; Reddy, Sunanda K; Suman,
Praveen; Mukherjee, Sharmila B; Dasgupta, Rajib; Tudu, Poma; Das, Manoja K; Bhutani, Vinod K;
Durkin, Maureen S; Pinto-Martin, Jennifer; Silberberg, Donald H; Sagar, Rajesh; Ahmed, Faruqueud-
din; Babu, Nandita; Bavdekar, Sandeep; Chandra, Vĳay; Chaudhuri, Zia; Dada, Tanuj; Dass, Rashna;
Gourie-Devi, M; Remadevi, S; Gupta, Jagdish C; Handa, Kumud K; Kalra, Veena; Karande, Sunil; Ko-
nanki, Ramesh; Kulkarni, Madhuri; Kumar, Rashmi; Maria, Arti; Masoodi, Muneer A; Mehta, Manju;
Mohanty, Santosh Kumar; Nair, Harikumaran; Natarajan, Poonam; Niswade, AK; Prasad, Atul; Rai,
Sanjay K; Russell, Paul SS; Saxena, Rohit; Sharma, Shobha; Singh, Arun K; Singh, Gautam B;
Sumaraj, Leena; Suresh, Saradha; Thakar, Alok; Parthasarathy, Sujatha; Vyas, Bhadresh; Panigrahi,
Ansuman; Saroch, Munish K; Shukla, Rajan; Rao, KV Raghava; Silveira, Maria P; Singh, Samiksha;
Vajaratkar, Vivek; (2018) Neurodevelopmental disorders in children aged 2-9 years: Population-based
burden estimates across five regions in India. PLoS medicine, 15 (7). e1002615. ISSN 1549-1277 DOI:
https://doi.org/10.1371/journal.pmed.1002615
Downloaded from: http://researchonline.lshtm.ac.uk/4653520/
DOI: https://doi.org/10.1371/journal.pmed.1002615
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
RESEARCH ARTICLE
Neurodevelopmental disorders in children
aged 2–9 years: Population-based burden
estimates across five regions in India
Narendra K. Arora1*, M. K. C. Nair2, Sheffali Gulati3, Vaishali Deshmukh1,
Archisman Mohapatra1, Devendra Mishra4, Vikram Patel5,6, Ravindra M. Pandey7,
Bhagabati C. Das8, Gauri Divan5, G. V. S. Murthy9, Thakur D. Sharma10, Savita Sapra3,
Satinder Aneja11, Monica Juneja4, Sunanda K. Reddy12, Praveen Suman13, Sharmila
B. Mukherjee11, Rajib Dasgupta14, Poma Tudu1, Manoja K. Das1, Vinod K. Bhutani15,
Maureen S. Durkin16, Jennifer Pinto-Martin17, Donald H. Silberberg18, Rajesh Sagar19,
Faruqueuddin Ahmed20, Nandita Babu21, Sandeep Bavdekar22, Vijay Chandra23,
Zia Chaudhuri24, Tanuj Dada25, Rashna Dass26, M. Gourie-Devi27, S. Remadevi28, Jagdish
C. Gupta29, Kumud K. Handa30, Veena Kalra31, Sunil Karande22, Ramesh Konanki32,
Madhuri Kulkarni33, Rashmi Kumar34, Arti Maria35, Muneer A. Masoodi36, Manju Mehta19,
Santosh Kumar Mohanty37, Harikumaran Nair2, Poonam Natarajan38, A. K. Niswade39,
Atul Prasad40, Sanjay K. Rai41, Paul S. S. Russell42, Rohit Saxena25, Shobha Sharma3,
Arun K. Singh43, Gautam B. Singh44, Leena Sumaraj45, Saradha Suresh46, Alok Thakar47,
Sujatha Parthasarathy48, Bhadresh Vyas49, Ansuman Panigrahi8, Munish K. Saroch50,
Rajan Shukla9, K. V. Raghava Rao51, Maria P. Silveira52, Samiksha Singh9,
Vivek Vajaratkar5,53
1 The INCLEN Trust International, New Delhi, India, 2 Kerala University of Health Sciences, Medical
College PO, Thrissur, Kerala, India, 3 Department of Paediatrics, All India Institute of Medical Sciences, New
Delhi, India, 4 Department of Paediatrics, Maulana Azad Medical College, New Delhi, India, 5 Sangath,
Bardez, Goa, India, 6 Department of Global Health and Social Medicine, Harvard Medical School, Boston,
Massachusetts, United States of America, 7 Department of Biostatistics, All India Institute of Medical
Sciences, New Delhi, India, 8 Department of Community Medicine, Kalinga Institute of Medical Sciences,
Bhubaneshwar, Odisha, India, 9 Indian Institute of Public Health, Hyderabad, Telangana, India, 10 Himachal
Foundation, Dharamshala, Kangra, Himachal Pradesh, India, 11 Department of Paediatrics, Lady Hardinge
Medical College, New Delhi, India, 12 Centre for Applied Research and Education on Neurodevelopmental
Impairments and Disability related Health Initiatives (CARENIDHI), New Delhi, India, 13 Department of
Paediatrics, Sir Ganga Ram Hospital, New Delhi, India, 14 Department of Social Medicine and Community
Health, Jawaharlal Nehru University, New Delhi, India, 15 Department of Paediatrics, Stanford University
School of Medicine and Lucile Packard Children’s Hospital, California, United States of America,
16 Department of Population Health Sciences and Paediatrics, and Waisman Center, University of Wisconsin
School of Medicine and Public Health, Madison, Wisconsin, United States of America, 17 University of
Pennsylvania School of Nursing and School of Medicine, Philadelphia, United States of America,
18 Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United
States of America, 19 Department of Psychiatry, All India Institute of Medical Science, New Delhi, India,
20 Integral Institute of Medical Sciences & Research, Integral University, Lucknow, Uttar Pradesh, India,
21 Department of Psychology, Delhi University, New Delhi, India, 22 Department of Paediatrics, Seth GS
Medical College & KEM Hospital, Mumbai, Maharashtra, India, 23 Department of Neurology, Paras Hospital,
Gurugram, Haryana, India, 24 Department of Ophthalmology, Lady Hardinge Medical College, New Delhi,
India, 25 Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New
Delhi, India, 26 Department of Paediatric Disciplines, Health City Hospital, Guwahati, Assam, India,
27 Department of Neurology, Institute of Human Behaviour and Allied Sciences & Department of
Neurophysiology, Sir Ganga Ram Hospital, New Delhi, India, 28 School of Health Policy and Planning, Kerala
University of Health Sciences, Thiruvananthapuram, Kerala, India, 29 Ali Yavar Jung National Institute of
Speech and Hearing Disabilities, Department of Empowerment of Persons with Disabilities, Kasturba Niketan,
New Delhi, India, 30 Department of ENT & Head Neck Surgery, Medanta Medicity, Gurugram, Haryana,
India, 31 Department of Paediatrics, Indraprastha Apollo Hospital, New Delhi, India, 32 Department of
Paediatric Neurology, Rainbow Children’s Hospital, Hyderabad, Telengana, India, 33 Department of
Paediatrics, Mumbai Port Trust Hospital, Mumbai, Maharashtra, India, 34 Department of Paediatrics,
King George Medical University, Lucknow, Uttar Pradesh, India, 35 Department of Neonatology, Post
Graduate Institute of Medical Education and Research and Dr. Ram Manohar Lohia Hospital, Delhi, India,
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002615 July 24, 2018 1 / 19
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Arora NK, Nair MKC, Gulati S, Deshmukh
V, Mohapatra A, Mishra D, et al. (2018)
Neurodevelopmental disorders in children aged
2–9 years: Population-based burden estimates
across five regions in India. PLoS Med 15(7):
e1002615. https://doi.org/10.1371/journal.
pmed.1002615
Academic Editor: Lars Åke Persson, London
School of Hygiene and Tropical Medicine, UNITED
KINGDOM
Received: January 15, 2018
Accepted: June 15, 2018
Published: July 24, 2018
Copyright: © 2018 Arora et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files. For need of any additional data, please contact
the INCLEN Data Access Committee (IDAC). The
IDAC is headed by Brigadier (Retd.) VK Panday,
Chief Operations Officer (vk.panday@inclentrust.
org); other members in the committee are: Dr
Ramesh Poluru, Senior Program Officer –
Biostatistics (ramesh.poluru@inclentrust.org), Dr
Rupak Mukhopadhyay, Senior Program Officer-
36 Department of Community Medicine, Government Medical College, Srinagar, Kashmir, India, 37 National
Trust, Department of Empowerment of Persons with Disabilities, Ministry of Social Justice & Empowerment,
Government of India, Delhi, India, 38 Vidya Sagar (formerly The Spastics Society of India), Chennai,
Tamil Nadu, India, 39 Department of Paediatrics, Government Medical College, Nagpur, Maharashtra,
India, 40 Social Welfare Department, Government of Bihar, Patna, India, 41 Department of Community
Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India, 42 Department of Child &
Adolescent Psychiatry and Facility for Children with Intellectual Disability, Christian Medical College,
Vellore, Tamil Nadu, India, 43 Rashtriya Bal Swasthya Karyakram, Ministry of Health and Family Welfare,
Nirman Bhawan, New Delhi, India, 44 Department of Otorhinolaryngology and Head and Neck Surgery
(ENT), Lady Hardinge Medical College, New Delhi, India, 45 Child Development Centre, Medical College
Campus, Thiruvananthapuram, Kerala, India, 46 Samarth, Chennai, Tamil Nadu, India, 47 Department
of Otolaryngology & Head-Neck Surgery, All India Institute of Medical Sciences, New Delhi, India,
48 Department of Pediatric Neurology, The Hospital for Sick Children (SickKids), The Peter Gilgan Centre for
Research and Learning, Toronto, Ontario, Canada, 49 Department of Paediatrics, M.P. Shah Government
Medical College & G.G. Hospital, Jamnagar, Gujarat, India, 50 Department of ENT, Dr. Rajender Prasad
Government Medical College, Kangra, Himachal Pradesh, India, 51 RVM Institute of Medical Sciences and
Research Center, Laxmakkapally, Telangana, India, 52 Department of Paediatrics, Goa Medical College,
Bambolim, Goa, India, 53 Department of Orthopedic Surgery, Goa Medical College, Bambolim, Goa, India
* nkarora@inclentrust.org
Abstract
Background
Neurodevelopmental disorders (NDDs) compromise the development and attainment of full
social and economic potential at individual, family, community, and country levels. Paucity
of data on NDDs slows down policy and programmatic action in most developing countries
despite perceived high burden.
Methods and findings
We assessed 3,964 children (with almost equal number of boys and girls distributed in 2–<6
and 6–9 year age categories) identified from five geographically diverse populations in India
using cluster sampling technique (probability proportionate to population size). These were
from the North-Central, i.e., Palwal (N = 998; all rural, 16.4% non-Hindu, 25.3% from sched-
uled caste/tribe [SC-ST] [these are considered underserved communities who are eligible
for affirmative action]); North, i.e., Kangra (N = 997; 91.6% rural, 3.7% non-Hindu, 25.3%
SC-ST); East, i.e., Dhenkanal (N = 981; 89.8% rural, 1.2% non-Hindu, 38.0% SC-ST);
South, i.e., Hyderabad (N = 495; all urban, 25.7% non-Hindu, 27.3% SC-ST) and West, i.e.,
North Goa (N = 493; 68.0% rural, 11.4% non-Hindu, 18.5% SC-ST). All children were
assessed for vision impairment (VI), epilepsy (Epi), neuromotor impairments including cere-
bral palsy (NMI-CP), hearing impairment (HI), speech and language disorders, autism spec-
trum disorders (ASDs), and intellectual disability (ID). Furthermore, 6–9-year-old children
were also assessed for attention deficit hyperactivity disorder (ADHD) and learning disor-
ders (LDs). We standardized sample characteristics as per Census of India 2011 to arrive at
district level and all-sites-pooled estimates. Site-specific prevalence of any of seven NDDs
in 2–<6 year olds ranged from 2.9% (95% CI 1.6–5.5) to 18.7% (95% CI 14.7–23.6), and for
any of nine NDDs in the 6–9-year-old children, from 6.5% (95% CI 4.6–9.1) to 18.5% (95%
CI 15.3–22.3). Two or more NDDs were present in 0.4% (95% CI 0.1–1.7) to 4.3% (95% CI
2.2–8.2) in the younger age category and 0.7% (95% CI 0.2–2.0) to 5.3% (95% CI 3.3–8.2)
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in the older age category. All-site-pooled estimates for NDDs were 9.2% (95% CI 7.5–11.2)
and 13.6% (95% CI 11.3–16.2) in children of 2–<6 and 6–9 year age categories, respec-
tively, without significant difference according to gender, rural/urban residence, or religion;
almost one-fifth of these children had more than one NDD. The pooled estimates for preva-
lence increased by up to three percentage points when these were adjusted for national
rates of stunting or low birth weight (LBW). HI, ID, speech and language disorders, Epi, and
LDs were the common NDDs across sites. Upon risk modelling, noninstitutional delivery,
history of perinatal asphyxia, neonatal illness, postnatal neurological/brain infections, stunt-
ing, LBW/prematurity, and older age category (6–9 year) were significantly associated with
NDDs. The study sample was underrepresentative of stunting and LBW and had a 15.6%
refusal. These factors could be contributing to underestimation of the true NDD burden in
our population.
Conclusions
The study identifies NDDs in children aged 2–9 years as a significant public health burden
for India. HI was higher than and ASD prevalence comparable to the published global
literature. Most risk factors of NDDs were modifiable and amenable to public health
interventions.
Author summary
Why was this study done?
• Neurodevelopmental disorders (NDDs) compromise the development and attainment
of full social and economic potential at individual, family, community, and country
levels.
• Lack of robust evidence regarding burden and risk factors impedes policy and program-
matic action for these conditions.
• Given the widespread prevalence of known risk factors, the anticipated burden of
NDDs in children in India could be considerably high, but adequate information is not
available.
What did the researchers do and find?
• In this population based study, the prevalence of NDDs among 2–9-year-olds was esti-
mated across five geographically diverse sites in India: North-Central (Palwal), North
(Kangra), East (Dhenkanal), West (North Goa), and South (Hyderabad).
• We assessed 3,964 chidren (2–<6 years: 2,057; 6–9 years: 1,907) for seven common
NDDs: vision impairment (VI), epilepsy (Epi), neuromotor impairments including
cerebral palsy (NMI-CP), hearing impairment (HI), speech and language disorders,
autism spectrum disorders (ASDs), and intellectual disability (ID). Two additional
Prevalence of childhood neurodevelopmental disorders across five regions in India
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NDDs (attention deficit hyperactivity disorder [ADHD] and learning disorders [LDs])
were also assessed in 6–9-year-old children.
• Prevalence of NDDs varied between sites. Site-specific prevalence of any of seven NDDs
in 2–<6year olds ranged between 2.9% and 18.7% and for any of nine NDDs in the 6–9-
year-old children from 6.5% to 18.5%. About one-fifth of these children had two or
more NDDs.
• HI and ID were the most common NDDs.
• The risk factors for childhood NDDs were as follows: children with history of delivery at
home, delayed crying or difficult breathing at birth (perinatal asphyxia), neonatal illness
requiring hospitalization, neurological/brain infections, low birth weight (LBW) (<2.5
kg) and/or birth before 37 weeks of gestation (prematurity), and stunting. NDDs were
also likely to be more frequent in older children (6–9 year age category).
What do these findings mean?
• Almost one in eight children of the age 2–9 years have at least one of the nine NDDs;
this is a conservative estimate, and actual burden might be higher due to limitations of
the study.
• The data suggested that the NDD burden can be substantially reduced in India by
addressing the risk factors which are amenable to public health interventions.
Introduction
“Neurodevelopment is a dynamic inter-relationship between genetic, brain, cognitive, emo-
tional and behavioural processes across the developmental lifespan. Significant and persistent
disruption to this dynamic process through environmental and genetic risk can lead to neuro-
developmental disorders and disability” [1]. Low-income communities and children living in
poverty are disproportionately affected by NDDs [2]. Communities most vulnerable to NDDs
often lack disease burden estimates to formulate policy decisions and implement programs to
address NDDs [3]. To better understand the spectrum of childhood NDDs, there is a need to
utilize valid and practical screening methodologies based on globally accepted disease defini-
tions [4]. To date, global health policy makers have relied on national census disability data,
even though such an approach grossly underestimates disability prevalence in children [5].
Censuses usually restrict themselves to the identification of gross and visible disabilities only
and utilize nonspecialized assessors and diagnostic tools [5,6]. Global and societal leaders have
urged that nations promote awareness of children with disabilities and advocate for their
healthcare services [3]. The United Nations General Assembly [7] and Agenda for Sustainable
Development [8] consider childhood disability an integral part of the global development
agenda and promote the use of evidences that address national and regional contexts and are
disaggregated by gender and age.
India has the world’s largest birth cohort (about 26 million) and is experiencing dynamic
improvements in both infant and child survival [9,10]. The neonatal, infant and under-five
Prevalence of childhood neurodevelopmental disorders across five regions in India
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mortality rates in India have shown significant decline during the last decade; improved sur-
vival of children and infants with high risk for NDDs is likely to result in higher community
prevalence, lest interventions are instituted concomitantly [11–13]. To address the challenge
of inadequate data, we convened a series of working groups to design and conduct a study of
population-level prevalence of childhood NDDs in India through a transdisciplinary approach.
Our aim was to determine the prevalence of NDDs among children aged 2–9 years in India
and identify potential demographic and individual risk factors that could be applied at the
national level. We decided to assess these children for nine common NDDs: vision impairment
(VI), epilepsy (Epi), neuromotor impairments including cerebral palsy (NMI-CP), hearing
impairment (HI), speech and language disorders, autism spectrum disorders (ASDs), intellec-
tual disability (ID), attention deficit hyperactivity disorder (ADHD), and learning disorders
(LDs).
Methods
We have reported this study as per the Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) guidelines (S1 STROBE Checklist).
Study design
We conducted a cross-sectional survey at five sites in India.Within each site, we used probabil-
ity proportionate to population size (PPS) cluster sampling to select households for the survey.
Investigator group
A Technical Advisory Group (TAG) comprising 55 transdisciplinary experts (51 from India
and four from the United States of America) provided guidance and oversight throughout the
project. The TAG included experts in paediatrics (paediatric neurology, developmental paedi-
atrics, general paediatrics), epidemiology, public health, social science, biostatistics, child psy-
chology, oto-rhino-laryngology, ophthalmology, and child psychiatry from 18 institutions.
The central coordinating office for the study was located at the INCLEN Executive Office in
New Delhi.
Settings
Considering the major geographic (North, South, East, West), demographic, sociocultural and
topographic (hilly terrain, plains, coastal regions) population heterogeneity in India, we
selected one district each from five states across the country with the following characteristics:
Kangra in Himachal Pradesh (Northern India; Himalayan terrain; altitude ranges from 427 to
6,401 metres; population: 94.3% rural; literacy: 85.7%); Palwal in Haryana (North-Central
India; plains; population: 77.3% rural; literacy: 69.3%); Dhenkanal in Odisha (Eastern India;
plains; population: 14.0% tribal, 90.0% rural; literacy: 70.6%); Hyderabad in erstwhile Andhra
Pradesh (now Telangana) (Southern India; plains; population: 100.0% urban; literacy: 83.3%);
and North Goa (West India; coastal; population: 59.9% urban; literacy: 90.7%) (demographic
details taken from Census of India, 2011) [14]. The technical capacity of the potential collabo-
rators and availability of infrastructural facilities and logistical support also contributed to
decisions regarding site selection. Villages and municipal wards as listed in the Census register
(Census of India, 2011) were the primary sampling units to select clusters of rural and urban
areas, respectively. Fifty clusters were identified at three sites. At Hyderabad and North Goa
sites, only 25 clusters were drawn due to limited finance availability. In total (five sites pooled),
Prevalence of childhood neurodevelopmental disorders across five regions in India
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we surveyed 200 clusters (42 urban and 158 rural). The data was collected between 5 December
2011 and 27 September 2012.
Participants and recruitment
An “eligible participant” was defined as a child in the age range of 2–9 years (24–119 months)
in the household. We requested the parent(s)/legal guardian(s) to provide written informed
consent for participation in the study and to visit the study clinic for the diagnostic work-up of
the child. We recruited 20 participants—five boys and five girls each from the age categories
2–<6 years and 6–9 years—in every cluster. A landmark located centrally in the cluster (e.g.,
temple, mosque, church, market place, panchayat office, central place) was identified with the
help of local people. The clusters were virtually divided into two halves, for enrolling boys
from one half and girls from the other. The direction for enumeration and choice of the first
household of each half of the cluster was decided through a random number. For households
with more than one eligible child, we recruited the eldest child in the even-numbered clusters
and the youngest child in odd-numbered clusters. One of the parents of the child was the pre-
ferred respondent. Children who dropped out from diagnostic assessment after initial enrol-
ment were replaced from the same cluster (matched for age category and gender) by
continuing enumeration of consecutive households.
Two research teams were engaged for data collection at each site: (a) the field team compris-
ing one physician and two social scientists, and (b) the diagnostic team comprising one physi-
cian, one audiologist/speech therapist, and two psychologists. The field teams identified the
eligible participants, obtained consent, collected information on demographic characteristics
including socioeconomic variables and risk factor variables at the participants’ residence, and
thereafter mobilized them to the partner institution (tertiary care hospital) study clinic for
detailed NDD work-up. At the hospital, under the supervision of the site investigators, mem-
bers of the diagnostic team conducted the following: (i) physician assessments for VI, Epi, and
NMI-CP; (ii) audiologist/speech therapist assessment for HI and speech and language disor-
ders; and (iii) psychologist assessment for ASD, ID, ADHD, and LD.
Training of the research teams
The TAG prepared standard operating procedures and training modules for the research
teams. Three-day structured training programs were conducted by a team of four multidisci-
plinary TAG members at partner hospitals for both field and diagnostic teams; 50% training
time was allocated for hands-on activities in the field. Thereafter, one quality assurance visit
per site by the TAG members was organized (all within eight weeks of starting the field work)
to ensure adherence to the assessment protocols. Additionally, the central coordinating site
conducted teleconferences with the site teams each time they completed data collection from
two clusters.
Study variables and measurement
Personal details and information on sociodemographic variables, asset variables for Standard
of Living Index (SLI), and biological and nutritional “risk factor” variables relevant for NDDs
were obtained for study participants. At the study clinics, every participant was assessed for
NDDs as per the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text
Revision (DSM-IV-TR) guidelines. Prior validation, reported use among Indian participants,
and feasibility of application in community settings were the criteria used by the TAG for zero-
ing in on the instruments used in the study (Table 1). As diagnostic tools for Epi, NMI-CP,
ASD, and ADHD satisfying the above criteria were not available, the INCLEN investigator
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team developed culturally adapted and context-relevant diagnostic tools for these four
conditions and validated them against globally established guidelines and tools [15–18]. The
instruments and examination formats for the NDDs were compiled into a child assessment
booklet (CAB) and applied consistently on all participants across the study sites. NDD evalua-
tions followed a specific algorithm to determine the clinical diagnosis. Since ADHD and LD
could be assessed only in older children (6–9-year-olds), the younger study participants
(2–<6-year-olds) were assessed for seven NDDs, and children aged 6–9 years were assessed
for all nine NDDs. A subcommittee of the TAG reviewed the data for resolution of diagnostic
ambiguity.
Sample size
Based on previous NDD prevalence reports from South Asian countries [28], we assumed that
about 10% of children aged 2–9 years could have at least one NDD. For an admissible absolute
Table 1. Diagnostic assessments for NDDs in study participants.
NDD assessed Diagnostic instrument Necessary precondition Method
Physician’s Station (Time taken: about 1 hour)
VI Cardiff Visual Acuity Test (for <3-year-old
children) [19,20]; LogMar E Chart (for 3-year-
old children) [21,22]
Visual acuity <6/18 in the better eye (uncorrected) was diagnosed as
VI
Test/examination
Epi INDT–EPI [15] The following conditions were not considered as “epilepsy”:
febrile seizures, seizures occurring within seven days of a head injury
or cerebrovascular hemorrhage, seizures during the course of an
active central nervous system infection, and in metabolic
disturbances like hypoglycemia, hypocalcaemia, hyponatremia, and
hypoxia
Interview
NMI–CP INDT–NMI [16] Interview, observation
and examination
Audiologist/Speech therapist’s Station (Time taken: about 1 hour)
HI OAE Audiometry [23] Exclusions: Impacted cerumen, foreign body, visible external ear
disease, and ear discharge (otitis media); Permanent unaided hearing
threshold of35 dB nHL in the better ear was diagnosed as HI
Test /examination
Speech and
Language
Disorders
LPT [24] Age3 years; Exclusions: HI, ID, and ASD Test and observation
Psychologists’ Station (Time taken: about 3 hours)
ASDs INDT–ASD [17] Interview and
observation
ID VSMS [25] for calculating SQ; Stanford Binet
Intelligence Scale (Kulshrestha–Indian adaptation)
[26] for calculating IQ
Children with SQ and IQ70 were diagnosed as intellectually
disabled
Interview and
observation
ADHD INDT–ADHD [18] Age6 years; Exclusions: ID and ASD Interview and
observation
LDs GLAD [27] Age6 years; IQ85; Presently going to school or had attended
school for at least 6 months (in case of school drop–outs) or studying
at home using conventional teaching methods; Exclusions: ID, HI
and VI
Test and observation
Abbreviations: ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; Epi, epilepsy; GLAD, Grade Level Assessment Device; HI, hearing
impairment; ID, intellectual disability; INDT–ASD, INCLEN Diagnostic Tool for Autism Spectrum Disorders; INDT–EPI, INCLEN Diagnostic Tool for Epilepsy;
INDT–NMI, INCLEN Diagnostic Tool for Neuro–Motor Impairments; IQ, intelligence quotient; LD, learning disorder; LPT, linguistic profile test; NDD,
neurodevelopmental disorder; NMI-CP, neuromotor impairments including cerebral palsy; OAE, oto-acoustic emission; SQ, social quotient; VI, vision impairment;
VSMS, Vineland Social Maturity Scale.
https://doi.org/10.1371/journal.pmed.1002615.t001
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error of ±2% at 95% confidence level, we arrived at the sample size of 864 participants per site.
Taking into account potential nonresponses and operational feasibility issues, 1,000 children
were enrolled per site. Due to paucity of resources and personnel, we reduced the sample size
to half at two sites (Hyderabad and North Goa); this increased the admissible absolute error to
±2.65% for these sites.
Analysis
For analysis, we used Microsoft Excel 2010 and STATA v12.0 [29]. Our analysis was guided by
a prospectively written statistical analysis plan at the time of preparation of this proposal for
funding (S1 Text). Nutritional status of participants (somatic measurements) was adjusted for
WHO Z-scores using WHO AnthroPlus software [30].We computed the SLI score for every
participant household, assigning scores for assets and household characteristics as per National
Family Health Survey-3 (NFHS-3) 2005–2006 (Demographic and Health Survey for India–3rd
Round) [31] and, using NFHS-3 state-specific cutoffs, assigned quintile status to each house-
hold. Thus, we generated both SLI scores and quintile statuses for the participants. The study
population was stratified according to age category (2–<6-year-old and 6-9-year-old), gender
(boy/girl), place of residence (rural/urban), and religion (Hindu/non-Hindu) and standard-
ized for these variables as per Census of India 2011 to arrive at respective district level esti-
mates. The data from the five sites was pooled and weighed against Census 2011 population
figures aggregated from respective districts for age, gender, place of residence (rural/urban),
and religion (Hindu/non-Hindu). As Census counts were not available according to nutri-
tional status of individuals, standardizing for stunting and low birth weight (LBW) could not
be done.
The complex survey module of STATA (SVYSET and SVY) was used for estimating the
prevalence and risk factors.
Risk factor analysis. To identify risk factors associated with presence of NDDs, we per-
formed multivariable logistic regression modelling on the background of SVY command of
STATA. The independent variables for the regression were adjusted into the model using sub-
ject knowledge. These were history of consanguinity, mental or neurological illness in the fam-
ily, medical complications during pregnancy, chorioamnionitis in the mother at the time of
index pregnancy, birth order (3 versus<3), multiple pregnancies, place of delivery (institu-
tional versus noninstitutional delivery), history of perinatal asphyxia, serious neonatal illness
(requiring hospitalization), traumatic brain injury, postnatal neurological infections (e.g.,
meningitis, encephalitis), LBW and/or prematurity, and stunting. Gender (boy/girl), place of
residence (rural/urban), education status of the respondent (“never been to school”/“ever been
to school”), religion (Hindu/non-Hindu), caste (SC-ST/rest), SLI score (continuous variable),
and age category (6–9-year-old versus 2–<6-year-old) were also adjusted into the model. We
estimated the population attributable fraction (PAF) [32,33] for the final multivariable logistic
model.
Data cleaning and processing
All CABs were scrutinized at two levels: by the research teams and the site investigators for
consistency and completeness of diagnostic assignment and again at the central coordinating
office. Discrepancies discovered at central coordinating office were resolved through commu-
nication with the site investigators (weekly teleconference) and TAG review (quality assurance
site visits and reviewing of CAB by TAG subcommittee). TAG members rechecked the diag-
nostic assignment in 10% of CABs of participants (chosen randomly) with NDD and an equal
number without NDD and did complete review of all participants labelled as “indeterminate.”
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Consent
Informed written consent was solicited from parents/guardian of the children prior to inclu-
sion in the study.
Ethics considerations
Ethics approval was obtained from the institutional review boards of India-CLEN (Indian Net-
work of INCLEN) and the participating sites. The study was conducted in compliance with the
World Medical Association (WMA) Declaration of Helsinki [34]. Children identified with “any
NDD” and/ or other medical conditions during the course of the study were referred to the
nearest appropriate tertiary care centre for management and followed up with due counselling.
Results
Table 2 illustrates the study recruitment profile for each site. Overall, the field teams
approached families of 4,739 children, of which 739 (15.6%) refused to participate. After
enrolling the targeted 4,000 children, 181 (4.5%) refused to complete diagnostic assessment, of
which 158 (4.0%) could be replaced with age category and gender-matched children from the
same cluster. Post hoc analyses revealed that dropouts and their replacements also matched for
anthropometric measurements and sociodemographic characteristics (S1 Table). The NDD
assessment could be done in 3,977 children (83.9% of the total approached; 99.4% of those
enrolled).
Table 2. Study recruitment profile.
Palwal Kangra Dhenkanal Hyderabad North Goa All sites pooled
Sampling frame 207,979 193,910 166,234 507,099 90,700 1,165,922
Number of clusters 50 50 50 25 25 200
Number of children identified as eligible for recruitment 1,189 1,181 1,185 597 587 4,739
Refused to participate 189
(15.9%)
181
(15.3%)
185
(15.6%)
97
(16.2%)
87
(14.6%)
739
(15.6%)
“No time to participate” 26
(13.8%)
24
(13.3%)
44
(23.8%)
6
(6.2%)
36
(4.1%)
136
(18.4%)
“Will not travel to study clinic” 46
(24.3%)
41
(22.7%)
48
(25.9%)
42
(43.3%)
51
(5.9%)
228
(30.9%)
“Primary care provider not at home” 90
(47.6%)
92
(50.8%)
45
(24.3%)
13
(13.4%)
0
(0.0%)
240
(32.3%)
No specific reason 27
(14.3%)
24
(13.3%)
48
(25.9%)
36
(37.1%)
0
(0.0%)
135
(18.3%)
Consented and Enrolled 1,000 1,000 1,000 500 500 4,000
Refused to complete diagnostic assessment after enrolment 46
(4.6%)
37
(3.7%)
64
(6.4%)
34
(6.8%)
0
(0.0%)
181
(4.5%)
Replaced (age category and gender matched) for those who did not come for
assessment
44
(4.4%)
37
(3.7%)
45
(4.5%)
32
(6.4%)
0
(0.0%)
158
(4.0%)
Available for diagnostic assessment 998
(99.8%)
1,000
(100.0%)
981
(98.1%)
498
(99.6%)
500
(100.0%)
3,977
(99.4%)
Assessment incomplete/Not properly done (dropped from analysis) 0
(0.0%)
3
(0.3%)
0
(0.0%)
3
(0.6%)
7
(1.4%)
13
(0.3%)
Available for analysis 998
(99.8%)
997
(99.7%)
981
(98.1%)
495
(99.0%)
493
(98.6%)
3,964
(99.1%)
 Reasons for noncompletion after enrollment (N = 181): “no time,” 133 (73.5%); “will not travel to study clinic,” 48 (26.5%). Values within parentheses indicate
percentages.
https://doi.org/10.1371/journal.pmed.1002615.t002
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During data review at the central coordinating office, errors in score computation done at
field sites were corrected in 358 out of 3,977 records (9%); 179 (4.5%) CABs were returned to
the primary site for completion, and all were obtained back. For quality assurance, the TAG
reviewed 50 random CABs per site for cases labelled with or without NDD, respectively, and
found no disagreements. The TAG reviewed an additional 174 CABs labelled as “indetermi-
nate”; of these, a definitive diagnosis was made in 161, and the remaining 13 were excluded
(due to incomplete information) from the study analysis, leaving a final number of 3,964 par-
ticipants (2,006 boys and 1,958 girls) for analysis.The background characteristics of study par-
ticipants are summarized in Table 3.
Prevalence of NDDs
Overall, we found 475 of 3,964 children (between the ages of 2 and 9 years) had at least one
NDD (12.0% [95% CI 11.0%–13.0%]). Among children with NDDs, 21.7% (95% CI 18.1%–
25.7%) had two or more NDDs; children with ASD (79.6%), NMI-CP (74.2%), ID (56.9%),
and Epi (55.1%) most frequently had coexisting NDD(s) (S2 Table). The district level preva-
lence estimates for NDDs across the five sites, upon weighing for age category, gender, place of
residence (rural/urban), and religion (Hindu/non-Hindu) as per Census 2011, is provided in
Table 4. There was site-specific variation in the prevalence: Dhenkanal had the lowest and Pal-
wal the highest prevalence of NDDs. HI, ID, speech and language disorders, Epi, and LDs were
among the most common NDDs across the sites.
There were no significant differences in the all-sites-pooled data for gender, place of resi-
dence, and religion weighed as per Census 2011: prevalence among boys 12.4% (95% CI
10.2%–15.0%) versus 10.2% (95% CI 8.4%–12.2%) in girls (p = 0.146); rural areas 12.6% (95%
CI 11.4%–13.9%) versus 10.1% (95% CI 7.9%–12.8%) from urban areas (p = 0.085); and in
Table 3. Background characteristics of study participants.
Characteristics Study sites (Percentage of participants)
Palwal
(N = 998)
Kangra
(N = 997)
Dhenkanal
(N = 981)
Hyderabad
(N = 495)
North Goa
(N = 493)
All sites pooled
(N = 3,964)
Place of residence: Rural 100.0 91.6 90.0 0.0 68.0 79.0
Gender: Female
2–<6-year-olds 49.4 49.1 49.9 46.3 50.2 49.2
6–9-year-olds 49.2 49.7 50.4 48.7 50.0 49.7
Family type: Nuclear 65.8 71.6 78.3 91.7 63.9 73.3
Religion: Non–Hindu 16.4 3.7 1.2 25.7 11.4 10.1
Ethnicity: SC-ST 25.3 25.3 38.0 27.4 18.5 27.8
Head of household: Literate 78.0 88.6 93.4 75.2 89.7 85.5
Either parent: Employed 99.0 88.0 99.7 91.2 86.0 93.9
Either parent as the respondent 55.4 91.5 99.1 81.4 97.2 83.7
Standard of Living Index
Poor 20.0 5.0 15.8 64.8 7.4 14.2
Lower Middle Class 26.7 23.0 12.4 25.6 19.1 13.0
Middle Class 25.3 41.0 10.2 9.0 33.7 21.0
Upper Middle Class 18.5 24.6 38.1 0.4 26.0 33.0
Rich 9.6 7.0 23.5 0.4 14.0 19.0
Can write his/her name in any language.
Computed against quintile distribution of respective state as per SLI.
Abbreviations: SC-ST, scheduled caste/tribe.
https://doi.org/10.1371/journal.pmed.1002615.t003
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non-Hindu families 11.7% (95% CI 8.5%–15.9%) versus those from Hindu families 11.0%
(95% CI 9.7%–12.5%) (p = 0.727).
Clinical profile of NDDs. Of the 62 cases of NMI-CP, 46.8% had spastic cerebral palsy
(CP), 22.6% had neuromuscular disorder (NMD), and 30.6% had other NMIs. ID (N = 144)
was assessed as mild (27%), moderate (13.8%), or severe and profound (3.5%); in the remain-
ing 55.6% (80/144), severity could not be determined, primarily due to associated comorbidi-
ties (62/80; 77.5%). Out of 44 cases of ASD, 52.3% were diagnosed as autism, 2.3% as Asperger,
38.0% as pervasive developmental disorder not otherwise specified (PDD-NOS), and 7.1%
were diagnosed to have childhood disintegrative disorders (CDDs). In 27 cases of ADHD,
44.4% had inattention, 11.1% had hyperactivity/impulsivity, and the remainder (44.4%) were
of mixed type. The assessment tool for Epi was not designed to determine the type of Epi.
Risk factors analysis
S3 Table enlists risk factor information for the study participants with and without NDDs.
Table 5 provides the independent risk factors in the multivariable regression model:
Table 4. Prevalence estimates of NDDs for the five study districts according to age categories.
Diagnosis#
Age category
(in years)
Sites
Palwal Kangra Hyderabad Dhenkanal North Goa All sites pooled
2–<6 6–9 2–<6 6–9 2–<6 6–9 2–<6 6–9 2–<6 6–9 2–<6 6–9
Any NDD
(at least 1)
18.7 18.5 9.5 15.3 9.6 14.4 2.9 6.5 8.0 16.0 9.2 13.6
(14.7–23.6) (15.3–22.3) (7.0–12.8) (11.8–19.7) (6.2–14.6) (9.9–20.4) (1.6–5.5) (4.6–9.1) (4.7–13.2) (11.2–22.4) (7.5–11.2) (11.3–16.2)
>1 NDD 4.3 5.3 1.6 3.3 3.3 2.4 0.4 0.7 1.5 3.0 2.3 2.6
(2.2–8.2) (3.3–8.2) (0.8–3.1) (2.0–5.4) (1.7–6.4) (0.8–7.1) (0.1–1.7) (0.2–2.0) (0.5–4.1) (1.4–6.2) (1.5–3.4) (1.7–4.0)
VI 0.3 0.0 1.0 0.5 1.0 0.9 0.9 0.7 0.0 0.8 0.7 0.6
(0.0–1.3) (0.0–0.7) (0.4–2.4) (0.1–1.8) (0.2–4.9) (0.1–6.2) (0.3–2.8) (0.2–2.0) (0–1.5) (0.2–3.6) (0.3–1.8) (0.2–1.9)
Epi 1.4 3.6 0.8 2.6 1.6 2.7 0.6 0.9 0.2 1.9 1.1 2.2
(0.7–2.9) (2.1–6.2) (0.4–2.0) (1.4–4.9) (0.7–3.7) (1.0–7.0) (0.2–1.9) (0.3–2.3) (0.0–1.8) (0.8–4.7) (0.6–1.7) (1.4–3.6)
NMI-CP 3.8 2.0 1.8 1.9 2.9 1.5 0.4 0.2 1.6 1.0 2.1 1.3
(1.8–7.8) (0.8–4.7) (0.8–3.7) (0.9–4.3) (1.3–6.4) (0.4–5.7) (0.1–1.7) (0.0–1.5) (0.4–7.1) (0.3–3.7) (1.3–3.4) (0.7–2.4)
HI 9.9 7.9 2.2 2.6 3.4 2.7 0.6 1.1 0.2 0.2 3.3 2.6
(7.2–13.6) (5.5–11.2) (1.1–4.7) (1.3–5.2) (1.4–7.7) (1.3–5.4) (0.1–2.7) (0.4–3.0) (0.0–1.8) (0.0–1.8) (2.3–4.8) (1.9–3.7)
Speech and
language
disorders
2.0 1.6 2.9 2.6 0.5 0.3 0.0 0.2 5.9 4.3 1.6 1.6
(1.0–3.8) (0.8–3.2) (1.5–5.3) (1.2–5.3) (0.0–3.6) (0.0–2.1) (0.0–0.7) (0.0–1.4) (3.2–10.6) (2.3–8.0) (1.0–2.4) (1.0–2.7)
ASDs 1.7 1.9 0.6 0.9 1.3 2.1 0.6 1.0 0.5 0.2 1.0 1.4
(0.6–4.8) (0.8–4.6) (0.2–1.7) (0.3–3.0) (0.5–3.3) (0.5–8.2) (0.2–1.9) (0.3–3.7) (0.1–2.0) (0.0–1.8) (0.6–1.6) (0.6–3.2)
ID 5.6 6.6 2.8 5.7 4.7 8.0 0.6 0.7 1.5 1.2 3.1 5.2
(3.3–9.4) (4.7–9.3) (1.6–5.1) (3.6–8.4) (2.6–8.2) (4.6–13.7) (0.2–2.7) (0.2–2.0) (0.5–4.1) (0.4–3.7) (2.2–4.2) (3.4–7.7)
ADHD - 0.8 - 2.3 - 0.5 - 0.7 - 1.9 - 1.0
(0.3–2.0) (1.1–4.7) (0.1–2.2) (0.2–2.0) (0.8–4.5) (0.6–1.5)
LDs - 1.5 - 1.2 - - - 2.0 - 7.6 - 1.6
(0.5–4.5) (0.4–3.3) (1.0–3.9) (3.9–14.2) (1.0–2.5)
Weighed according to district population for age category, gender, place of residence (rural/urban), and religion (Hindu/non-Hindu) as per Census of India, 2011.
Values in parentheses indicate 95% CI.
ADHD and LD were assessed only in the 6–9 year age category, and therefore, prevalence for 2–<6 and 6–9 year age category were calculated separately.
Abbreviations: ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; CI, confidence interval; Epi, epilepsy; HI, hearing impairment; ID,
intellectual disability; LD, learning disorder; NDD, neurodevelopmental disorder; NMI-CP, neuromotor impairments including cerebral palsy; VI, vision impairment.
https://doi.org/10.1371/journal.pmed.1002615.t004
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noninstitutional delivery, history of perinatal asphyxia, history of neonatal illness, postnatal
neurological (brain) infections, stunting, LBW (<2.5 kg)/prematurity (gestation <37 weeks),
and older (6–9 years) age category were statistically significantly associated with “any NDD.”
The PAF was 36.8% (95% CI 27.2%–45.1%) for modifiable and statistically significant risk fac-
tors. We also undertook multivariable analysis for identifying risk factors for specific NDDs
(S4 Table). The risk factors for “any NDD” were variably present with specific NDDs as well.
Discussion
The study reports the prevalence of NDDs in children aged 2 to 9 years obtained through a
population-based, multisite survey across five regions in India. The prevalence of NDDs varied
across the five study sites despite using the same diagnostic tools with application of consistent
methodology and training for the assessors. NDD prevalence might truly vary across regions,
particularly in a large country like India, due to heterogenous distribution of risk factors and
biological factors, if any. Dhenkanal, situated in central Odisha, with a sizeable tribal popula-
tion, has high under-five mortality rate (80 per 1,000 live births) [35] and is endemic for hemo-
globinopathies [36] and cerebral malaria (cerebral malaria in Odisha has up to six times higher
risk of mortality among children) [37,38]. It has been reported that the risk of mortality in chil-
dren with NDDs may be high in environments of poor economic development, weak health
Table 5. Multivariable logistic regression analysis for risk factors for NDDs#.
Risk factors Reference AOR 95% CI p value PAF 95% CI
Modifiable risk factors 43.8 (32.9–52.9)
Consanguinity No consanguinity 1.4 (0.7–2.8) 0.343 2.2 (0.03–4.3)
Neurological or mental illness in the family No neurological or mental illness in the family 1.0 (0.7–1.6) 0.823 3.4 (0.2–6.4)
Medical complications during pregnancy No medical complications during pregnancy 1.0 (0.6–1.9) 0.938 2.4 (0.0–5.6)
Chorioamnionitis No chorioamnionitis 1.5 (0.8–3.0) 0.235 2.6 (0.5–4.7)
Birth order3 Birth order <3 1.4 (0.9–2.2) 0.129 11.3 (6.6–15.8)
Multiple pregnancies Single pregnancy 0.6 (0.3–1.4) 0.282 0.05 (0.0–1.8)
Place of delivery (Non-institutional) Institutional 1.5 (1.0–2.3) 0.042 18.2 (11.6–24.4)
Perinatal asphyxia No perinatal asphyxia 1.9 (1.0–3.5) 0.039 6.3 (3.3–9.2)
Neonatal illness (requiring hospitalization) No neonatal illness 2.2 (1.5–3.1) <0.001 10.4 (6.9–13.8)
Traumatic brain injury No traumatic brain injury 1.8 (0.9–3.4) 0.087 3.5 (1.4–5.5)
Post-natal neurological/brain infections No Post-natalneurological/ brain infection 3.3 (1.3–8.8) 0.011 3.4 (1.9–4.9)
Stunting No stunting 1.6 (1.1–2.4) 0.012 11.8 (6.4–17.0)
LBW (<2.5kg)/prematurity (gestation <37weeks) Birth weight2.5 kg and gestation37 weeks 1.6 (1.1–2.5) 0.022 7.2 (3.4–10.9)
Nonmodifiable risk factors 31.5 (8.0–49.1)
Gender (Boy) Girl 1.2 (0.9–1.6) 0.335 13.1 (4.2–21.1)
Place of Residence (Rural) Urban 0.7 (0.4–1.1) 0.090 18.7 (1.8–32.6)
Education (never been to school) Ever been to school 1.0 (0.6–1.6) 0.983 11.2 (5.8–16.4)
Religion (non-Hindu) Hindu 0.8 (0.5–1.3) 0.332 1.6 (0.0–4.6)
Caste (SC-ST) Rest 1.2 (0.8–1.7) 0.345 0.9 (0.0–6.2)
SLI score (Continuous variable) 0.99 (0.97–1.00) 0.082
Age category(6–9 years) 2–<6 years 1.4 (1.0–1.9) 0.023 14.8 (6.3–22.5)
# Weighed according to national population for age category, gender, place of residence (rural/urban), and religion (Hindu/non-Hindu) as per Census of India, 2011.
 Statistically significant (p< 0.05).
 PAF for all modifiable and nonmodifiable factors taken together:76.9% (95% CI 45.6%–90.2%); PAF for statistically significant modifiable factors only: 36.8% (95% CI
27.2%–45.1%).
Abbreviations: AOR, adjusted odds ratio; LBW, low birth weight; NDD, neurodevelopmental disorder; SC-ST, scheduled caste/tribe; SLI, Standard of Living Index.
https://doi.org/10.1371/journal.pmed.1002615.t005
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systems, and high child mortality [4,39]. The higher prevalence of HI in Palwal contributed to
a higher overall prevalence of NDD in this site over others. According to an earlier study,
repeated respiratory infections and high rates of chronic suppurative otitis media were associ-
ated with a high rate of deafness in 5–15-year-old children in the area [40].
Literature suggests that the prevalence of NDDs and their profiles vary considerably within
and between geographies [4,41–45]; this has commonly been attributed to methodological var-
iability [4] but can also be seen in studies that used common diagnostic tools and criteria and
common data collection methods across sites. For example, based on parent-reported diagno-
sis, Boyle and colleagues [46] reported the prevalence of ASD in the United States of America
to be 0.7%, but when systematic community-based assessment was done at 11 sites by the
Autism and Developmental Disabilities Monitoring Network, overall prevalence of ASD was
almost twice that of the previous study (1.5%) [47]. The Ten Questions (TQ) screen for disabil-
ity was uniformly applied in a study of 18 low- and middle-income countries (LMICs); the
prevalence of children aged 2–9 years at high risk for disability ranged between 3% (Uzbeki-
stan) and 48% (Central African Republic), with a median prevalence of 23% [48]. In the two-
phased studies with TQ in the similar age group, the prevalence of moderate to severe forms of
disability varied between 0.5% and 9.4% in several LMICs [49–51].
In the Indian census form, there are four questions for collecting information on eight
severe and obviously visible disabilities, including NDDs. According to Census of India 2011
data, the prevalence of all disabilities in the age category 0–4 years was 1.1%, and in the age cat-
egory 5–9 years, it was 1.5% [52]. These figures were almost 10 times less than what we
reported in the present study after a systematic, comprehensive, community-based assessment
exclusively for NDDs; the study findings were likely to present a more factual picture of the
population-based prevalence of NDDs in different parts of India.
The cumulative prevalence of NDDs was higher in the older age category (6–9 years) as
compared to the younger age category (2–<6 years). According to published literature, obser-
vation of higher prevalence of NDDs with increasing age in childhood might be due to the fol-
lowing: (a) accumulation of childhood-onset causes and exposures, such as infections, injuries,
and nutritional deficiencies; and (b) increased ability to recognize and diagnose conditions
such as CP, ID, and behavioral disorders as age advanced [53]. In the regression model in
which we fitted age as a categorical variable (6–9-year-old versus 2–<6-year-old, as a refer-
ence), it emerged as a statistically significant predictor of NDD (Table 5). We could have also
possibly arrived at this observation because participants in the older age category were assessed
for two additional NDDs (i.e., ADHD and LD).
Almost one-fifth of the children with NDDs had another comorbid NDD. Similarly, there
was clustering of risk factors in the same individuals. We looked for the various modifiable risk
factors significantly associated with occurrence of any or a cluster of NDDs in the same individ-
ual. The odds of any NDD among children with two or more risk factors and three or more risk
factors were 2.1 (95% CI 1.5–2.9) and 2.6 (95% CI 1.7–4.0), respectively. Walker and colleagues
have suggested that cumulative exposure to risks starting from the prenatal period affects the
developmental trajectories and lays the foundation for NDDs; these risk factors therefore
require early identification and integrated interventions [54]. The frequent coexistence of ASD,
NMI-CP, ID and/or Epi in (S2 Table) could be suggestive of common precursor events [55].
The results of the study have to be interpreted in the light of its limitations; 15.6% refusal to
participate might be reflective of sociobehaviroal complexities associated with a child with
NDD in the family (e.g., disability, fear, denial, guilt, blame, different dimensions of stigma
and discrimination) that could in turn influence participation in such diagnostic evaluations
[56,57]. The study sample was not representative of India (S5 Table); particularly, the sample
was underrepresentative of stunting and LBW, and that could be contributing to
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underestimation of the true NDD burden in the study population. The stunting and LBW sta-
tus of the children were not available in the Census data and therefore could not be adjusted
together with other variables like age, gender, place of residence, and religion. The national
rates (NFHS-4, 2015–2016) of stunting (38.4%) and LBW (18.2%) were available, and when
these were applied separately to all-site-pooled estimates, prevalence of NDD in the 2–<6 year
age category increased from 9.2% to 10.9% and 12.3%, respectively. Similarly, in the 6–9 year
age group, weighing for these conditions led to increase in the estimates from 13.6% to 16.8%
and 14.0%, respectively. The study was not designed to determine the social bias of “gender-
selective treatments” on child survival, growth, and development [58]. The group has now vali-
dated a revised version of the Epi instrument to ascertain the types of Epi, including some of
the ones not detected with the present tool [59].
Our study provided the first population-based multisite data on the burden of NDDs in 2–
9-year-old children from India. We developed four new diagnostic tools that were culturally
adapted and validated against international guidelines that use global normative data [15–18];
the tools were applied in the field by trained professionals with stringent quality control frame-
works. While measurement of clinical conditions such as lack of vision or Epi is fairly compa-
rable to other international measures (and prevalence rates are thus directly comparable), the
same does not apply to the assessment of cognitive, attention, and learning skills, in which dis-
ability estimates would likely be substantially different if high-income population norms
would be applied instead of an Indian reference population.
The study highlighted NDDs in children as an important public health challenge of consider-
able significance with substantial within-country variations. Most of the significant risk factors
identified through the study were modifiable and could potentially be addressed by investments
in public health to improve maternal/newborn care and child nutrition. Several emerging econ-
omies have been able to address these risk factors effectively [60]. The findings were important
in the context of the Universal Health Care (UHC) agenda of the Government of India and the
recently launched national child health program (“Rashtriya Bal Swasthya Karyakram”) [61].
These data will have relevance for India’s response to the needs of the children who are most
vulnerable and their families and might also inform the policies of other countries that share
similar socioeconomic milieu and healthcare situations, particularly in South Asia [54,62].
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